Calcipotriol modulates IL-22 receptor expression and keratinocyte proliferation in IL-22-induced epidermal hyperplasia

Journal of Dermatological Science

Volumn 71, Issue 1, 2013, Pages 76-77

  Moniaga, Catharina Sagita ^a   Egawa, Gyohei ^a   Miyachi, Yoshiki ^a   Kabashima, Kenji ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG;

CELL PROLIFERATION; DRUG MECHANISM; EPIDERMIS HYPERPLASIA; HUMAN; LETTER; MITOSIS INHIBITION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS;

CALCITRIOL; CELL PROLIFERATION; DERMATOLOGIC AGENTS; DOWN-REGULATION; EPIDERMIS; HUMANS; HYPERPLASIA; INTERLEUKINS; KERATINOCYTES; RECEPTORS, INTERLEUKIN; TISSUE CULTURE TECHNIQUES;

EID: 84879010065     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.03.011     Document Type: Letter

References (10)

1. Boniface K., Guignouard E., Pedretti N., Garcia M., Delwail A., Bernard F.X., et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 2007, 150:407-415.
2. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
3. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009, 119:3573-3585.
4. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005, 174:3695-3702.
5. Wolk K., Haugen H.S., Xu W., Witte E., Waggie K., Anderson M., et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) 2009, 87:523-536.
6. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
7. Ma H.L., Liang S., Li J., Napierata L., Brown T., Benoit S., et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008, 118:597-607.
8. Kristl J., Slanc P., Krasna M., Berlec A., Jeras M., Strukelj B. Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2. Pharm Res 2008, 25:521-529.
9. Takahashi H., Ibe M., Kinouchi M., Ishida-Yamamoto A., Hashimoto Y., Iizuka H. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 2003, 31:21-28.
10. Caruso R., Botti E., Sarra M., Esposito M., Stolfi C., Diluvio L., et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 2009, 15:1013-1015.